Prostate-specific membrane antigen-mediated theragnostics in prostate cancer

Investig Clin Urol. 2021 Sep;62(5):497-499. doi: 10.4111/icu.20210275.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antigens, Surface / physiology*
  • Glutamate Carboxypeptidase II / physiology*
  • Humans
  • Male
  • Prostatic Neoplasms / diagnosis*
  • Prostatic Neoplasms / therapy*

Substances

  • Antigens, Surface
  • FOLH1 protein, human
  • Glutamate Carboxypeptidase II